A detailed history of Citigroup Inc transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Citigroup Inc holds 58,333 shares of SLN stock, worth $408,914. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,333
Previous 58,333 -0.0%
Holding current value
$408,914
Previous $1.11 Million 4.24%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

BUY
$20.61 - $25.71 $1.2 Million - $1.5 Million
58,333 New
58,333 $1.37 Million

Others Institutions Holding SLN

About Silence Therapeutics plc


  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $252M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.